Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chong, S. | - |
dc.contributor.author | Lee, K.S. | - |
dc.date.accessioned | 2021-06-18T13:42:07Z | - |
dc.date.available | 2021-06-18T13:42:07Z | - |
dc.date.issued | 2007 | - |
dc.identifier.issn | 1470-7330 | - |
dc.identifier.issn | 1470-7330 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/47012 | - |
dc.description.abstract | Positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) has been known to increase diagnostic accuracy in differentiating benign and malignant lung lesions and to improve identification of lymph node and extrathoracic metastasis in pulmonary neoplasms. In this review, the authors describe the spectrum of integrated PET/CT findings on neuroendocrine (NE) tumors of the lung. We also demonstrate the usefulness of this imaging modality in patients with known or suspected NE tumors of the lung. © 2007 International Cancer Imaging Society. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung | - |
dc.type | Article | - |
dc.identifier.doi | 10.1102/1470-7330.2007.0028 | - |
dc.identifier.bibliographicCitation | Cancer Imaging, v.7, no.1, pp 195 - 201 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-38449105411 | - |
dc.citation.endPage | 201 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 195 | - |
dc.citation.title | Cancer Imaging | - |
dc.citation.volume | 7 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Chest | - |
dc.subject.keywordAuthor | CT | - |
dc.subject.keywordAuthor | Lung | - |
dc.subject.keywordAuthor | Oncologic imaging | - |
dc.subject.keywordAuthor | PET/CT | - |
dc.subject.keywordPlus | diagnostic agent | - |
dc.subject.keywordPlus | fluorodeoxyglucose f 18 | - |
dc.subject.keywordPlus | radiopharmaceutical agent | - |
dc.subject.keywordPlus | cancer staging | - |
dc.subject.keywordPlus | computer assisted emission tomography | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | lung tumor | - |
dc.subject.keywordPlus | neuroendocrine tumor | - |
dc.subject.keywordPlus | pathology | - |
dc.subject.keywordPlus | positron emission tomography | - |
dc.subject.keywordPlus | prognosis | - |
dc.subject.keywordPlus | review | - |
dc.subject.keywordPlus | scintiscanning | - |
dc.subject.keywordPlus | Fluorodeoxyglucose F18 | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Lung Neoplasms | - |
dc.subject.keywordPlus | Neoplasm Staging | - |
dc.subject.keywordPlus | Neuroendocrine Tumors | - |
dc.subject.keywordPlus | Positron-Emission Tomography | - |
dc.subject.keywordPlus | Prognosis | - |
dc.subject.keywordPlus | Radiopharmaceuticals | - |
dc.subject.keywordPlus | Tomography, Emission-Computed | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.